Companies

DarioHealth Corp. is a publicly traded company listed on Nasdaq under the ticker DRIO[2]. The company maintains its headquarters at 322 W 57th Street, Suite 33B, New York, New York, 10019[1]. According to the Securities and Exchange Commission, DarioHealth operates in the surgical and medical instruments and apparatus industry[3]. The company was previously registered with the SEC under the name LabStyle Innovations Corp. from November 2011 to July 2016[4]. In its most recent annual report, DarioHealth reported revenue of $22.4 million for the year ending December 31, 2025, and total assets of $110.1 million[5].

NYC headquarters

  • SEC filings list the business address of DarioHealth Corp. as 322 W 57TH ST. #33B, NEW YORK, NY, 10019.[1]

financials

  • Reported revenue of $22.4 million for the year ending 2025-12-31 and total assets of $110.1 million in its most recent annual report to the SEC.[5]

Something wrong or missing? Send a correction. Fixed within 24 hours.